Brick & Kyle Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.27M | Buy |
10,129
+261
| +3% | +$110K | 1.89% | 21 |
|
|
2025
Q1 | $4.83M | Buy |
9,868
+30
| +0.3% | +$14.7K | 2.22% | 17 |
|
|
2024
Q4 | $5.12M | Buy |
9,838
+783
| +9% | +$407K | 2.18% | 16 |
|
|
2024
Q3 | $5.57M | Sell |
9,055
-182
| -2% | -$112K | 2.39% | 15 |
|
|
2024
Q2 | $5.11M | Sell |
9,237
-60
| -0.6% | -$33.2K | 2.11% | 17 |
|
|
2024
Q1 | $5.36M | Sell |
9,297
-124
| -1% | -$71.4K | 2.37% | 14 |
|
|
2023
Q4 | $5M | Sell |
9,421
-9
| -0.1% | -$4.78K | 2.49% | 15 |
|
|
2023
Q3 | $4.77M | Buy |
9,430
+51
| +0.5% | +$25.8K | 2.53% | 13 |
|
|
2023
Q2 | $4.88M | Buy |
9,379
+428
| +5% | +$223K | 2.61% | 16 |
|
|
2023
Q1 | $5.16M | Sell |
8,951
-6
| -0.1% | -$3.46K | 2.96% | 12 |
|
|
2022
Q4 | $4.93M | Sell |
8,957
-83
| -0.9% | -$45.7K | 2.87% | 10 |
|
|
2022
Q3 | $4.61M | Sell |
9,040
-26
| -0.3% | -$13.3K | 2.8% | 11 |
|
|
2022
Q2 | $4.9M | Sell |
9,066
-48
| -0.5% | -$26K | 2.75% | 12 |
|
|
2022
Q1 | $5.38M | Sell |
9,114
-9,120
| -50% | -$5.39M | 2.61% | 12 |
|
|
2021
Q4 | $12.2M | Buy |
18,234
+9,146
| +101% | +$6.1M | 2.83% | 9 |
|
|
2021
Q3 | $5.26M | Buy |
9,088
+175
| +2% | +$101K | 2.67% | 12 |
|
|
2021
Q2 | $4.5M | Sell |
8,913
-32
| -0.4% | -$16.2K | 2.35% | 18 |
|
|
2021
Q1 | $4.1M | Buy |
+8,945
| New | +$4.1M | 2.26% | 21 |
|
|
2017
Q2 | – | Sell |
-16
| Closed | -$2K | – | 330 |
|
|
2017
Q1 | $2K | Hold |
16
| – | – | ﹤0.01% | 402 |
|
|
2016
Q4 | $2K | Hold |
16
| – | – | ﹤0.01% | 414 |
|
|
2016
Q3 | $3K | Buy |
+16
| New | +$3K | ﹤0.01% | 406 |
|